Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

Upadacitinib effectively treats psoriasis and lichen planus together.

Upadacitinib improves life quality for Alopecia Areata patients without worsening skin issues.

Ritlecitinib works well and is safe for treating alopecia areata.

Vitamin A treatment reduced abnormal cell growth and improved skin conditions in rats with tumors.

LDE225 is a promising skin-applied treatment for basal cell carcinoma with good skin penetration and effectiveness.

Cepharanthine shows promise as a natural anticancer treatment.

Quercetin and kaempferol may be effective and safe natural treatments for hair loss.

New cancer drugs often cause skin and nail problems.

Bexarotene 1% topical gel helped some patients with alopecia areata regrow hair.

Ruxolitinib effectively and safely regrows hair in alopecia patients.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

Finasteride may improve prostate cancer treatment outcomes.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Ritlecitinib helps regrow hair in alopecia areata and is safe for long-term use.

Ritlecitinib may help young adults with severe alopecia areata when ketoconazole doesn't work.

Two drugs, tofacitinib and ruxolitinib, may help regrow hair by activating hair follicles.

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

Forsythiaside A helps protect cells and liver from damage by reducing oxidative stress and boosting antioxidants.

DFMO may help control hair growth and treat cancer.

CS12192 effectively treats alopecia areata with better safety than current options.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

Chrysin makes docetaxel more effective and reduces its side effects in lung cancer treatment.

A man's severe skin reaction from cancer treatment improved with early diagnosis and proper medication.

Patients with alopecia areata face challenges accessing Janus kinase inhibitors, but some see positive results.

JAK inhibitors show promise for treating various skin diseases.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.